These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10200128

  • 1. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
    Sato N, Sugimura T, Akagi T, Yamakawa R, Hashino K, Eto G, Iemura M, Ishii M, Kato H.
    Pediatr Int; 1999 Feb; 41(1):1-7. PubMed ID: 10200128
    [Abstract] [Full Text] [Related]

  • 2. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.
    Furukawa S, Matsubara T, Umezawa Y, Motohashi T, Ino T, Yabuta K.
    Eur J Pediatr; 1994 Sep; 153(9):663-7. PubMed ID: 7957426
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.
    Terai M, Shulman ST.
    J Pediatr; 1997 Dec; 131(6):888-93. PubMed ID: 9427895
    [Abstract] [Full Text] [Related]

  • 4. Intravenous gamma-globulin for Kawasaki disease.
    Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T.
    Acta Paediatr Jpn; 1991 Dec; 33(6):799-804. PubMed ID: 1801560
    [Abstract] [Full Text] [Related]

  • 5. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S.
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [Abstract] [Full Text] [Related]

  • 6. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome.
    Hsu CH, Chen MR, Hwang FY, Kao HA, Hung HY, Hsu CH.
    Pediatr Infect Dis J; 1993 Jun; 12(6):509-12. PubMed ID: 8345983
    [Abstract] [Full Text] [Related]

  • 8. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.
    Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP.
    N Engl J Med; 1991 Jun 06; 324(23):1633-9. PubMed ID: 1709446
    [Abstract] [Full Text] [Related]

  • 9. High-dose intravenous gammaglobulin for Kawasaki disease.
    Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T.
    Lancet; 1984 Nov 10; 2(8411):1055-8. PubMed ID: 6209513
    [Abstract] [Full Text] [Related]

  • 10. Patients diagnosed with Kawasaki disease before the fifth day of illness have a higher risk of coronary artery aneurysm.
    Nomura Y, Masuda K, Yoshinaga M, Sameshima K, Miyata K.
    Pediatr Int; 2002 Aug 10; 44(4):353-7. PubMed ID: 12139556
    [Abstract] [Full Text] [Related]

  • 11. Overview of pharmacological treatment of Kawasaki disease.
    Onouchi Z, Kawasaki T.
    Drugs; 1999 Nov 10; 58(5):813-22. PubMed ID: 10595862
    [Abstract] [Full Text] [Related]

  • 12. [Study on coronary artery lesions in patients with Kawasaki disease: recent 9 years' experience].
    Wu JR, Hwang KP, Tu JG, Dai ZK, Huang TY.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Jan 10; 9(1):27-38. PubMed ID: 7682261
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J.
    Eur J Pediatr; 2009 Nov 10; 168(11):1315-21. PubMed ID: 19159953
    [Abstract] [Full Text] [Related]

  • 14. Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications.
    Sawaji Y, Haneda N, Yamaguchi S, Kajino Y, Kishida K, Seto S, Konishi N, Waki K, Baba K, Arisawa K, Kamiya T, Mori C.
    Acta Paediatr Jpn; 1998 Jun 10; 40(3):218-25. PubMed ID: 9695293
    [Abstract] [Full Text] [Related]

  • 15. Coronary risks after high-dose gamma-globulin in children with Kawasaki disease.
    Morikawa Y, Ohashi Y, Harada K, Asai T, Okawa S, Nagashima M, Katoh T, Baba K, Furusho K, Okuni M, Osano M.
    Pediatr Int; 2000 Oct 10; 42(5):464-9. PubMed ID: 11059532
    [Abstract] [Full Text] [Related]

  • 16. The treatment of Kawasaki syndrome with intravenous gamma globulin.
    Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP.
    N Engl J Med; 1986 Aug 07; 315(6):341-7. PubMed ID: 2426590
    [Abstract] [Full Text] [Related]

  • 17. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Aug 07; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 18. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
    Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP, Pediatric Heart Network Investigators.
    N Engl J Med; 2007 Feb 15; 356(7):663-75. PubMed ID: 17301297
    [Abstract] [Full Text] [Related]

  • 19. [Clinical manifestations and effects of IVGG in patients with Kawasaki disease].
    Hwang KP, Wu JR, Huang LY, Liou CC, Huang TY.
    Kaohsiung J Med Sci; 1996 Mar 15; 12(3):159-66. PubMed ID: 8709183
    [Abstract] [Full Text] [Related]

  • 20. Management of Kawasaki disease in the British Isles.
    Dhillon R, Newton L, Rudd PT, Hall SM.
    Arch Dis Child; 1993 Dec 15; 69(6):631-6; discussion 637-8. PubMed ID: 8285773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.